Metabolic Research Focus: Designed for studying weight kinetics, glycemic shifts, and appetite regulation mechanisms using this premium Semaglutide + Cagrilintide blend
REDEFINE 1 (NCT05567796), REDEFINE 2 (NCT05394519), REDEFINE 3 (NCT05669755), REDEFINE 4 (NCT06131437), REDEFINE 11 (NCT07011667), REIMAGINE 2 (NCT06065540)
In November 2025, we were granted a provisional patent for a multi-stage oral delivery system that overcomes the destructive acidic environment of the stomach
In some embodiments, the otoprotectant is a compound of Formula (VIII) having the structure of Formula (VIIIa): In some embodiments, the otoprotectant is a compound of Formula (IX): wherein: R 1 is C 6 -C 10 aryl or C 3 -C 9 heteroaryl, wherein C 6 -C 10 aryl and C 3 -C 9 heteroaryl are optionally substituted with one or more R 4